TMG finishes annual survey of PACS, teleradiology sites
TMG finishes annual survey of PACS, teleradiology sitesTechnology Marketing Group has released a PACS census that includes data on more than 1700 PACS and teleradiology sites in the U.S. TMG has learned that one-third of the survey respondents
TMG finishes annual survey of PACS, teleradiology sites
Technology Marketing Group has released a PACS census that includes data on more than 1700 PACS and teleradiology sites in the U.S. TMG has learned that one-third of the survey respondents plan to purchase more PACS equipment, among other findings.
The survey also includes data on the U.S. market as a whole and on individual sites. Facility profiles include: installed PACS equipment by component; applications by location and function; and 1996-1998 equipment purchase plans with budget ranges. In compiling the census, TMG conducted interviews with key staff at hospitals of 200 beds or more in the U.S., as well as clinics, imaging centers, and other non-hospital settings.
The TMG survey was conducted in conjunction with professional societies such as the Society for Computer Applications in Radiology. Companies in the diagnostic imaging and PACS market provided funding for the survey, according to Des Plaines, IL-based TMG.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.
